Pharmaniaga Berhad,a PN17 company, appears to be on track with its regularisation plan. We speak with Managing Director Zulkifli Jaafar on the company’s restructuring efforts, how they plan to grow operations, and what this means for the future of one of Malaysia’s key pharmaceutical players which has a lucrative government concession agreement.